Next Generation Sequencing

We sat down with John Hood, co-founder, and CEO of Endeavor BioMedicines, to hear about their focus on precision medicine and more.

Advances in genome testing are helping to improve the outcomes for people who are battling cancer.  There is cutting-edge technology offering more accurate diagnosis, and today’s technologies allow doctors to match treatments with each patient’s cancer.  Dr. Francisco Velazquez from PAML joins us to explain.